Bioengineer Receives NSF Award to Study Cell Migration in a 3D Environment
December 16, 2016
…environment. The work has applications for the study of cancers, wound healing and regenerative medicine.
Your search for “Cancer Research” returned 1388 results
Cetuximab Outperforms Durvalumab in Treatment of Head and Neck Cancers
November 19, 2024
The standard treatment for head and neck cancer, cisplatin, can’t be given to some patients due to pre-existing conditions. A new study compares the efficacy of two alternatives: cetuximab, a monoclonal antibody, and durvalumab, an immune checkpoint inhibitor.
UC San Diego Researcher Receives $6.25 Million Grant
October 14, 2013
The Leukemia & Lymphoma Society has awarded Thomas J. Kipps, MD, PhD, Distinguished Professor of Medicine at the University of California, San Diego School of Medicine, with a 5-year, $6.25 million Specialized Center of Research program grant to support research on chronic lymphocytic leukemia.
Iris and Matthew Strauss Give $2 Million to Endow Faculty Chair at UC San Diego
June 22, 2021
Longtime supporters of cancer research and patient care at Moores Cancer Center at UC San Diego Health have given University of California San Diego School of Medicine $2 million to establish the Iris and Matthew Strauss Chancellor’s Endowed Chair in Head and Neck Surgery.
Higher Levels of Vitamin D Correspond to Lower Cancer Risk, Researchers Say
April 6, 2016
Researchers at University of California, San Diego School of Medicine report that higher levels of vitamin D – specifically serum 25-hydroxyvitamin D – are associated with a correspondingly reduced risk of cancer. The findings are published in the April 6, online issue of PLOS ONE.
Nanoparticle Vaccine Could Curb Cancer Metastasis to Lungs by Targeting a Protein
October 18, 2023
UC San Diego engineers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. Its success lies in targeting a protein known to play a central role in cancer growth and spread, rather than targeting the primary tumor itself.
Inhibiting Enzyme Helps Cancer Immunotherapy Work Better
August 3, 2020
UC San Diego researchers discovered that people with an inactive RNA-editing enzyme respond better to cancer immunotherapy, and inhibitors of the enzyme help mice with difficult-to-treat cancers live longer.
Alternative Approach Uses Sound Waves to Treat Prostate Cancer
February 24, 2022
UC San Diego Health is the first hospital system in San Diego County to employ high-intensity, focused ultrasound (HIFU) for minimally invasive prostate cancer treatment.
Changing Lives: Carol Vassiliadis Names Hospital with $8.5 Million to Jacobs Medical Center
October 16, 2014
…passed away from colon cancer in 2002. Carol began her tradition of philanthropy at UC San Diego initially to honor her late husband’s legacy with a fellowship for cancer prevention, followed by support for the Healthy Eating and Living Program at UC San Diego Moores Cancer Center. Now, she has…
Enzyme Offers New Therapeutic Target for Cancer Drugs
June 21, 2012
Researchers at the University of California, San Diego School of Medicine have uncovered a new signal transduction pathway specifically devoted to the regulation of alternative RNA splicing, a process that allows a single gene to produce or code multiple types of protein variants. The discovery, published in the June 27,…
